← Eichor
Condition: Conjunctival Diseases Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Conjunctival Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Phase 3 · 38 location(s) · Baxis Pharmaceuticals, Inc. · NCT06911424Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome
Phase N/A · 1 location(s) · Taipei Veterans General Hospital, Taiwan · NCT06771427Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
Phase 2 · 1 location(s) · National Institute of Dental and Craniofacial Research (NIDC · NCT07281456Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
Phase N/A · 2 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT04198740FARD (RaDiCo Cohort) (RaDiCo-FARD)
Phase N/A · 15 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05954416Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy
Phase 3 · 2 location(s) · Regeneron Pharmaceuticals · NCT07309432An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
Phase 3 · 77 location(s) · Dompé Farmaceutici S.p.A · NCT07519902Development of a Mobile Terminal-Based Intelligent Detection System for Multiple Anterior Segment Diseases of the Eye
Phase N/A · 1 location(s) · Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT07634913Conjunctival Transpositional Surgery for Primary Pterygium
NA · 1 location(s) · Zahedan University of Medical Sciences · NCT07343011Safety and Efficacy of SUM-191 for Patients With Bacterial Conjunctivitis
Phase 1/Phase 2 · 1 location(s) · Senju USA, Inc. · NCT07565103Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells
Phase 4 · 2 location(s) · Rigshospitalet, Denmark · NCT04957329Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Neg
Phase 1 · 1 location(s) · Fred Hutchinson Cancer Center · NCT05098210An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants W
Phase 2 · 24 location(s) · Dompé Farmaceutici S.p.A · NCT07503886Peridontal and Intestinal Microbiota in Patients With Gingival Scarring Pemphigoid
Phase N/A · 3 location(s) · Centre Hospitalier Universitaire de Nice · NCT06291350Kelulut Honey for Allergic Conjunctivitis and Dry Eye Symptoms
NA · 1 location(s) · Universiti Sains Malaysia · NCT07273747A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vern
Phase 2 · 11 location(s) · Laboratoires Thea · NCT07169695Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops
Phase 1 · 1 location(s) · Huons Co., Ltd. · NCT06263998Comparison of the Healing Properties on Corneal Cells of Groth Factor-enriched Plasma and Autologous Serum From Aniridia
Phase N/A · 1 location(s) · Fondation Ophtalmologique Adolphe de Rothschild · NCT054005903% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis
Phase 3 · 1 location(s) · The University of Hong Kong · NCT06903884Three-dimensional Analysis of EMMPRIN on Conjunctival Epithelial Cells Surface in Severe Dry Eye Syndrome (ALTESSE)
Phase N/A · 1 location(s) · Fondation Ophtalmologique Adolphe de Rothschild · NCT03358979RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)
NA · 2 location(s) · University of North Carolina, Chapel Hill · NCT07322302Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05797415Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis
Phase 2 · 1 location(s) · Telios Pharma, Inc. · NCT06686472Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis
Phase 2 · 1 location(s) · Telios Pharma, Inc. · NCT07220408THE ROLE OF HEXAMIDINE DIISETHIONATE (ZAMIDINE®) 1MG/ML 0.6ML EYE DROPS IN THE PROPHYLAXIS OF SURGERY OFTALMIC
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06771908Analysis of Videodermatoscopic Parameters of Ocular, Periocular, Conjunctival and Palpebral Neoformations
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06714799
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.